I'll agree. KM should not be "worth" 25% less than JT here.
Right now, we have a few catalysts coming up. Prepare it, ER and Chinese approval. Plus any possible "wild card" events, which is basically anything that we don't know.
Considering the launch in Europe, one would have expected this to trend towards 10, valuing sales without competitors, not devaluing it over lawsuits.
I'm looking forward to the ER, either Karim's first real ER shows that he isn't a moron, or I'll be back to call everyone here morons for tacitly supporting him and not pushing for change. We know what doesn't work, so do something different!
Prepare-it 2 will be interesting. I'd have expected topline data if it was good (same as Reduce-it), but who knows why they aren't releasing anything yet. I'd love for this to be a R-it style rip and I'd gladly GTFO and never have this boat anchor in my portfolio again.
Lastly, China approval. I'd expect it later November, but maybe it's sooner. If we're so lucky, it hits next week and they can talk about it on the ER.
Long story short, November is the first "exciting" month in a long while. I seriously hope Amarin isn't "same old" and botches all three items. That would be actually impressive. And piss me the hell off.
News 
Market Data 
Discover 
